REVIEW

Translational medicine: untranslated regions and the stop codons

Rebrikov DV1, Tarasov VV2
About authors

1 Pirogov Russian National Research Medical University, Moscow, Russia

2 Laboratory of Bioactive Compounds, Research Institute of Pharmacy,
I. M. Sechenov First Moscow State Medical Unversity, Moscow, Russia

Correspondence should be addressed: Denis V. Rebrikov
ul. Ostrovityanova, d. 1, Moscow, Russia, 117997; moc.liamg@vokirberd

Received: 2016-12-20 Accepted: 2016-12-24 Published online: 2017-01-19
|

4P medicine is impossible without an efficient transfer of advanced laboratory techniques (such as regenerative cell technology, high-throughput sequencing, genome editing, etc.) into clinical practice. Translational Medicine — a new scientific field, designed to reduce the time of transfer of long-term achievements of fundamental scientific research in the development of innovative product applications. However, on the path of innovation in medicine, there are a number of natural barriers that do not allow to go to practice unsafe and ineffective products. The system of these barriers must be dynamic and up-to-date. As well as the education system for work at the "science–medicine" junction.

Keywords: translational medicine, innovations, preclinical trials, clinical trials

КОММЕНТАРИИ (0)